Pfizer Earnings Preview: Get Ahead of the Analysts

Pfizer (NYSE:PFE) will report earnings before markets open on Tuesday, April 30th. Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.

Here is your Cheat Sheet to Pfizer Earnings:

Earnings Expectations: Analysts expect earnings of $0.56 per share on revenues of $14.01 billion. Currently, the company’s P/E ratio stands at 16.01.

Analyst Trends:

Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.58 to a profit $0.6. For the current year, the average estimate is a profit of $2.28, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Pfizer has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 48,300 50,010 65,160 65,260 58,990
Diluted EPS ($) 1.20 1.23 1.02 1.27 1.94

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 16,140 15,400 15,060 13,980 15,070
Diluted EPS ($) 0.1868 0.24 0.43 0.43 0.8555

Past Performance:
Pfizer has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]